Amneal Pharmaceuticals (AMRX) EGM 2026 summary

Opening remarks and agenda

• The meeting was called to order at 9:00 A.M. and conducted virtually, with rules of conduct and agenda provided on the meeting website.

• Participants were instructed to limit questions to items being voted on and to follow meeting procedures.

Specific resolutions to be voted on

• Approval of the Membership Interest Purchase Agreement for the acquisition of 100% of Kashiv BioSciences, LLC.

• Approval of the issuance of 28,942,108 shares of Class A common stock to sellers in connection with the acquisition, in compliance with Nasdaq rules.

• Proposal to adjourn the meeting under certain circumstances, though not necessary to consider at this meeting.

Board and executive committee updates

• The Independent Committee and Board of Directors unanimously recommended voting in favor of both the transaction and stock issuance proposals.